KIT and colorectal carcinoma: In conclusion, the current study illustrates that RUNX1 functions as an oncogene to facilitate metastasis and EMT in CRC by directly interacting with β-catenin and activating KIT transcription to enhance the Wnt/β-catenin signalling pathway (Fig. 6d).